Investopedia on MSN43m
Novo Nordisk Stock Rises on Earnings Beat, Narrowed OutlookFull-Year Outlook Narrowed at Top and Bottom Ends "The sales growth is driven by increasing demand for our GLP-1-based ...
Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent to $79.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback